I have a different view. In the last announcement they expressed that the team has consistent difficulty to estimate the growing demand hence the forward planning of the production. Therefore my takeaway is that the last guidance is still conservative and does not reflect their upper range internal estimations. Anyone interested a revisit just read it again and tell me if you have the same takeaway.
As everybody agrees it is a good management team. A good/experienced team do not overestimate and run the risk of under deliver. It is more likely that they will always do the opposite.
- Forums
- ASX - By Stock
- A2M
- A2M $3 Party
A2M $3 Party, page-83
-
- There are more pages in this discussion • 2,173 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.81 |
Change
-0.090(1.84%) |
Mkt cap ! $3.482B |
Open | High | Low | Value | Volume |
$4.92 | $4.95 | $4.80 | $8.716M | 1.802M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 10795 | $4.81 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.83 | 5662 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 10795 | 4.810 |
14 | 50515 | 4.800 |
10 | 88280 | 4.790 |
8 | 128503 | 4.780 |
4 | 31267 | 4.770 |
Price($) | Vol. | No. |
---|---|---|
4.830 | 5662 | 1 |
4.840 | 6237 | 1 |
4.850 | 50303 | 2 |
4.890 | 15000 | 2 |
4.930 | 15000 | 2 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online